Matches in SemOpenAlex for { <https://semopenalex.org/work/W2402498049> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2402498049 abstract "Primary and secondary glomerulonephritis are a heterogeneous group of disorders characterized by glomerular inflammation with an immune-mediated pathogenesis. Considering the severe side effects of the immunosuppressive drugs, the therapeutic approach remains a challenge for the nephrologists. Corticosteroids, cytotoxic agents such as cyclophosphamide, or calcineurin inhibitors such as cyclosporine and tacrolimus, azathioprine and mycophenolate mofetil can all be used for the treatment of glomerulonephritis. Several studies has been published to better understand the pathogenesis of these diseases and to identify the drugs with lower toxicity. Different mechanisms involve, directly or indirectly, the B cells in the pathogenesis of glomerulonephritis. For this reason, the attention of the nephrologists has been focused on the identification of drugs that act at this level, such as chimeric monoclonal antibodies. Rituximab, binding to the CD20 receptor expressed on the surface of B cells, induces their apoptosis and persistent depletion for 6-9 months. B cells contribute to the immune response by the maturation into plasma cells with consequent antibody production, the processing and presentation of the antigen to T cells and the production of various cytokines. For these reasons, the potential role of these drugs in the treatment of primitives and secondary glomerulonephritis is clear. In this review, we aimed to evaluate the use of rituximab in the treatment of these diseases, by focusing on the results of the most recent clinical trials." @default.
- W2402498049 created "2016-06-24" @default.
- W2402498049 creator A5010183050 @default.
- W2402498049 creator A5018790889 @default.
- W2402498049 creator A5043478567 @default.
- W2402498049 creator A5065421355 @default.
- W2402498049 creator A5087811410 @default.
- W2402498049 date "2016-02-06" @default.
- W2402498049 modified "2023-09-23" @default.
- W2402498049 title "[Use of rituximab in primary and secondary glomerulonephritis]." @default.
- W2402498049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26845209" @default.
- W2402498049 hasPublicationYear "2016" @default.
- W2402498049 type Work @default.
- W2402498049 sameAs 2402498049 @default.
- W2402498049 citedByCount "0" @default.
- W2402498049 crossrefType "journal-article" @default.
- W2402498049 hasAuthorship W2402498049A5010183050 @default.
- W2402498049 hasAuthorship W2402498049A5018790889 @default.
- W2402498049 hasAuthorship W2402498049A5043478567 @default.
- W2402498049 hasAuthorship W2402498049A5065421355 @default.
- W2402498049 hasAuthorship W2402498049A5087811410 @default.
- W2402498049 hasConcept C126322002 @default.
- W2402498049 hasConcept C128057223 @default.
- W2402498049 hasConcept C154317977 @default.
- W2402498049 hasConcept C159654299 @default.
- W2402498049 hasConcept C18031839 @default.
- W2402498049 hasConcept C202751555 @default.
- W2402498049 hasConcept C203014093 @default.
- W2402498049 hasConcept C2775998817 @default.
- W2402498049 hasConcept C2776694085 @default.
- W2402498049 hasConcept C2776755627 @default.
- W2402498049 hasConcept C2776760755 @default.
- W2402498049 hasConcept C2779134260 @default.
- W2402498049 hasConcept C2780091579 @default.
- W2402498049 hasConcept C2780368995 @default.
- W2402498049 hasConcept C2780653079 @default.
- W2402498049 hasConcept C2780942790 @default.
- W2402498049 hasConcept C2909675724 @default.
- W2402498049 hasConcept C2911091166 @default.
- W2402498049 hasConcept C55493867 @default.
- W2402498049 hasConcept C71924100 @default.
- W2402498049 hasConcept C86803240 @default.
- W2402498049 hasConceptScore W2402498049C126322002 @default.
- W2402498049 hasConceptScore W2402498049C128057223 @default.
- W2402498049 hasConceptScore W2402498049C154317977 @default.
- W2402498049 hasConceptScore W2402498049C159654299 @default.
- W2402498049 hasConceptScore W2402498049C18031839 @default.
- W2402498049 hasConceptScore W2402498049C202751555 @default.
- W2402498049 hasConceptScore W2402498049C203014093 @default.
- W2402498049 hasConceptScore W2402498049C2775998817 @default.
- W2402498049 hasConceptScore W2402498049C2776694085 @default.
- W2402498049 hasConceptScore W2402498049C2776755627 @default.
- W2402498049 hasConceptScore W2402498049C2776760755 @default.
- W2402498049 hasConceptScore W2402498049C2779134260 @default.
- W2402498049 hasConceptScore W2402498049C2780091579 @default.
- W2402498049 hasConceptScore W2402498049C2780368995 @default.
- W2402498049 hasConceptScore W2402498049C2780653079 @default.
- W2402498049 hasConceptScore W2402498049C2780942790 @default.
- W2402498049 hasConceptScore W2402498049C2909675724 @default.
- W2402498049 hasConceptScore W2402498049C2911091166 @default.
- W2402498049 hasConceptScore W2402498049C55493867 @default.
- W2402498049 hasConceptScore W2402498049C71924100 @default.
- W2402498049 hasConceptScore W2402498049C86803240 @default.
- W2402498049 hasIssue "6" @default.
- W2402498049 hasLocation W24024980491 @default.
- W2402498049 hasOpenAccess W2402498049 @default.
- W2402498049 hasPrimaryLocation W24024980491 @default.
- W2402498049 hasRelatedWork W156737206 @default.
- W2402498049 hasRelatedWork W1981194021 @default.
- W2402498049 hasRelatedWork W2018591286 @default.
- W2402498049 hasRelatedWork W2106356784 @default.
- W2402498049 hasRelatedWork W2107607526 @default.
- W2402498049 hasRelatedWork W2154452726 @default.
- W2402498049 hasRelatedWork W2227968444 @default.
- W2402498049 hasRelatedWork W2402498049 @default.
- W2402498049 hasRelatedWork W3138621588 @default.
- W2402498049 hasRelatedWork W93661301 @default.
- W2402498049 hasVolume "32" @default.
- W2402498049 isParatext "false" @default.
- W2402498049 isRetracted "false" @default.
- W2402498049 magId "2402498049" @default.
- W2402498049 workType "article" @default.